Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients

By Brechot J.M.   Chevret S.   Nataf J.   Le Gall C.   Fretault J.   Rochemaure J.   Chastang C.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 385-391

Elsevier

Access to resources Recommend Favorite

Cell Proliferation in Ovarian Carcinoma: Superior Accuracy of S-Phase Fraction (SPF) by DNA Labeling Index versus Flow Cytometric SPF, Lack of Independent Prognostic Power for SPF and DNA Ploidy, and Limited Effect of SPF on Tumor Growth Rate

By Meyer J.S.   Gersell D.J.   Yim S.  

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 466-476

Elsevier

Access to resources Recommend Favorite

Prognostic Significance of DNA Content and S-Phase Fraction in Epithelial Ovarian Carcinomas Analyzed by Image Cytometry

By Reles A.E.   Gee C.   Schellschmidt I.   Schmider A.   Unger M.   Friedmann W.   Lichtenegger W.   Press M.F.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 3-13

Elsevier

Access to resources Recommend Favorite

A comparison between flow cytometric assessment of S-phase fraction and Nottingham histologic grade as prognostic instruments in breast cancer

By Sundquist M.  

Breast Cancer Research and Treatment, Vol. 63, Iss. 1, 2000-09 ,pp. : 11-15

Springer Publishing Company

Access to resources Recommend Favorite

S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer

By Bryant J.   Fisher B.   Gündüz N.   Costantino J.P.   Emir B.  

Breast Cancer Research and Treatment, Vol. 51, Iss. 3, 1998-10 ,pp. : 239-253

Springer Publishing Company

Access to resources Recommend Favorite